Stratos Wealth Partners, Ltd. Johnson & Johnson Transaction History

Stratos Wealth Partners, Ltd.

$6.14 Billion
Q2 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 115,969 shares of JNJ stock, worth $19.1 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

115,969

Previous 119,002 2.55%

Holding current value

$19.1 Million

Previous $18.8 Million 9.96%

% of portfolio

0.28%

Previous 0.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$144.38 - $157.78 $437,904 - $478,546	-3,033 Reduced 2.55%	115,969 $17 Million
Q1 2024 Apr 16, 2024	BUY	$155.22 - $162.74 $115,949 - $121,566	747 Added 0.63%	119,002 $18.8 Million
Q4 2023 Jan 24, 2024	SELL	$145.6 - $158.88 $661,606 - $721,950	-4,544 Reduced 3.7%	118,255 $18.5 Million
Q3 2023 Oct 24, 2023	BUY	$155.75 - $174.48 $614,745 - $688,672	3,947 Added 3.32%	122,799 $19.1 Million
Q2 2023 Jul 18, 2023	SELL	$154.35 - $166.11 $1.32 Million - $1.42 Million	-8,541 Reduced 6.7%	118,852 $19.7 Million
Q1 2023 Apr 27, 2023	SELL	$151.05 - $180.26 $2.62 Million - $3.13 Million	-17,358 Reduced 11.99%	127,393 $19.7 Million
Q4 2022 Jan 19, 2023	BUY	$160.2 - $179.79 $294,127 - $330,094	1,836 Added 1.28%	144,751 $0
Q3 2022 Oct 24, 2022	SELL	$161.33 - $179.52 $1.29 Million - $1.44 Million	-8,025 Reduced 5.32%	142,915 $23.3 Million
Q2 2022 Jul 22, 2022	BUY	$168.19 - $186.01 $1.13 Million - $1.25 Million	6,721 Added 4.66%	150,940 $26.8 Million
Q1 2022 Apr 26, 2022	SELL	$158.14 - $179.59 $204,949 - $232,748	-1,296 Reduced 0.89%	144,219 $25.6 Million
Q4 2021 Jan 14, 2022	SELL	$155.93 - $173.01 $297,046 - $329,584	-1,905 Reduced 1.29%	145,515 $24.9 Million
Q3 2021 Oct 19, 2021	BUY	$161.5 - $179.47 $52,972 - $58,866	328 Added 0.22%	147,420 $23.8 Million
Q2 2021 Jul 19, 2021	BUY	$159.48 - $171.07 $1.25 Million - $1.34 Million	7,813 Added 5.61%	147,092 $24.2 Million
Q1 2021 Apr 27, 2021	BUY	$153.07 - $170.48 $195,929 - $218,214	1,280 Added 0.93%	139,279 $22.9 Million
Q4 2020 Jan 29, 2021	SELL	$137.11 - $157.38 $918,774 - $1.05 Million	-6,701 Reduced 4.63%	137,999 $21.7 Million
Q3 2020 Oct 29, 2020	BUY	$140.38 - $153.83 $224,608 - $246,128	1,600 Added 1.12%	144,700 $21.5 Million
Q2 2020 Jul 28, 2020	BUY	$128.81 - $155.51 $1.09 Million - $1.31 Million	8,437 Added 6.27%	143,100 $20.1 Million
Q1 2020 May 04, 2020	BUY	$111.14 - $153.99 $142,370 - $197,261	1,281 Added 0.96%	134,663 $17.7 Million
Q4 2019 Jan 29, 2020	SELL	$127.5 - $146.44 $279,990 - $321,582	-2,196 Reduced 1.62%	133,382 $19.5 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $17 Million - $19 Million	133,822 Added 7620.84%	135,578 $17.5 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $17 Million - $19.1 Million	-134,051 Reduced 98.71%	1,756 $20.9 Million
Q2 2019 Aug 06, 2019	BUY	$131.15 - $144.24 $168,134 - $184,915	1,282 Added 0.95%	135,807 $18.9 Million
Q1 2019 May 07, 2019	SELL	$125.72 - $139.79 $174,750 - $194,308	-1,390 Reduced 1.02%	134,525 $18.8 Million
Q4 2018 Feb 08, 2019	SELL	$122.84 - $147.84 $1.09 Million - $1.31 Million	-8,871 Reduced 6.13%	135,915 $17.5 Million
Q3 2018 Nov 02, 2018	BUY	$121.58 - $142.88 $749,054 - $880,283	6,161 Added 4.44%	144,786 $20 Million
Q2 2018 Aug 13, 2018	BUY	$119.4 - $131.76 $2.72 Million - $3 Million	22,801 Added 19.69%	138,625 $16.8 Million
Q1 2018 May 10, 2018	BUY	$125.1 - $148.14 $790,632 - $936,244	6,320 Added 5.77%	115,824 $14.8 Million
Q4 2017 Feb 09, 2018	SELL	$131.22 - $143.62 $182,133 - $199,344	-1,388 Reduced 1.25%	109,504 $15.3 Million
Q3 2017 Nov 07, 2017	BUY	$129.47 - $135.38 $14.4 Million - $15 Million	110,892	110,892 $14.4 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account

Stratos Wealth Partners, Ltd. Johnson & Johnson Transaction History